Zum Hauptinhalt springen

Suchergebnisse

UB Katalog
Ermittle Trefferzahl…

Artikel & mehr
377 Treffer

Suchmaske

Suchtipp für den Bereich Artikel & mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur / Strichcode".

Suchergebnisse einschränken oder erweitern

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Gefunden in

Art der Quelle

Schlagwort

Publikation

Sprache

377 Treffer

Sortierung: 
  1. Figure 4—figure supplement 2. Lateral positioning of ROBO1-expressing longitudinal axons in Nova1/2 dKO embryos. ; (A) Anti-ROBO1 staining of transverse sections of E12.5 lumbar spinal cords. The antibodies do not distinguish between isoforms. ROBO1 was expressed at a low level on precrossing axons and was highly upregulated on postcrossing axons in both WT and Nova1/2 dKO embryos. ROBO1-expressing axons displayed the same lateral positioning defect as anti-L1 labeled axons (compare with Figure 4B). Reducing Robo1(e6b+) partially rescued the lateral positioning defect in Nova1/2 dKO embryos, while reducing Robo2(e6b+) alone did not rescue. Reducing Robo1/2(e6b+) together further rescued the defect. Arrows indicate the lateral funiculus (LF) and ventral funiculus (VF). Scale bar, 50 μm. (B) Quantification of the lateral positioning of ROBO1-expressing axons in A. Data are represented as the mean ± SD (one-way ANOVA and Bonferroni post test; animal numbers and p values are indicated; ns, not significant). (C) Anti-ROBO2 staining of transverse sections of E12.5 lumbar spinal cords. The antibodies do not distinguish between isoforms. ROBO2 was primarily expressed by axons in the lateral funiculi, and the overall patterns were comparable between the WT and Nova1/2 dKO embryos. (D) Anti-ROBO1 and anti-ROBO2 staining in the corresponding KO embryos, showing the specificity of the antibodies. The Robo1 KO was generated by trapping the protein product in intracellular compartments (Friedel et al., 2005). ROBO1 expression was seen in neuronal cell bodies but not in axons in Robo1 KO spinal cords, as previously reported (Long et al., 2004).
    2019
    unknown
  2. 2019
    unknown
  3. 2019
    unknown
  4. Figure 3—figure supplement 1. Alternative splicing of Robo1/2. ; (A) Quantitative RT-PCR of a constitutive exon in Robo1/2 showing the total Robo mRNA levels in Nova1/2 dKO dorsal spinal cord at E11.5. (B) Western blotting analysis of ROBO1/2 protein levels in E11.5 spinal cords. The antibodies do not distinguish between the alternative isoforms. (C) Quantitative RT-PCR analysis of Robo1 and Dutt1 levels in Nova1/2 dKO dorsal spinal cord, which are two alternative mRNAs produced from two different promoters (Nural et al., 2007),. Other alternative 5’ sequences of Robo1 and Robo2 were also tested and no significant difference was observed between WT and Nova1/2 dKO spinal cords. (D) Quantification of Robo1 exon 6b expression in nine different genotype combinations of Nova1 and Nova2. Robo1 exon 6b level was sensitive to Nova1/2 gene copy number. Robo2 exon 6b level was regulated in a similar dose-sensitive manner. Data are normalized to the WT and are represented as the mean ± SD (Student’s t-test in A,C; one-way ANOVA and Bonferroni post test in D; n = 3 for all genotypes; p value are indicated; ns, not significant). (E) Genomic DNA included in exon 6b splicing reporters. Exon 6b sequences are capitalized and in bold. Potential NOVA-binding sites (YCAY repeats; Y = C/U) that were mutated in the splicing assays are in bold and in red. Two additional candidate NOVA-binding sites (in black, bold, and lower case) are present in Robo1 intron 6b but were not mutated, as the mutations themselves constitutively repressed exon 6b inclusion. (F) Splicing assays of Robo2 exon 21. Schematic shows the Robo2 exon 21 splicing reporter, which contains the complete genomic sequences between exons 20 and 22 (5.8 kb). Candidate NOVA-binding sites (7 YCAY repeats) are located in intron 20. Expression of e21- and e21+ isoforms was detected by semi-quantitative RT-PCR. NOVAs had no direct effect on Robo2 exon21 alternative splicing.
    2019
    unknown
  5. Figure 7. The β2AR mutant selectively supports carvedilol-induced augmentation of LTCC activity in neurons. ; (A–B) β1AR/β2AR double knockout (DKO) mouse hippocampal neurons on 7–10 days in vitro (DIV) were cotransfected with FLAG-tagged β2AR WT (A) or mutant (B) and HA-tagged LTCC α11.2 subunit, 24 hr later cells were either mock treated (NT), or treated for 5 min with 10 nM isoproterenol (ISO) or carvedilol (CAR), fixed and labeled with anti-FLAG and a phospho-specific antibody for S1928 phosphorylated α11.2. Confocal images show mutant β2AR losts the ability of promoting LTCC phosphorylation upon ISO stimulation but remained the ability upon CAR stimulation in neurons. Scale bar, 10 μm. Representative of 6 images for each condition, three experiments. (C) Representative single channel recordings of LTCC CaV1.2 currents using 110 mM Ba2+ as charge carrier in DKO neurons on 7–10.days DIV expressing mutant β2AR after depolarization from −80 to 0 mV in in control patches (mutant) and patches containing 1 μM isoproterenol (ISO) or 1 μM carvedilol (CAR) in the patch pipette. Shown are 20 consecutive sweeps from representative experiments. Arrows throughout the figure indicate the 0-current level (closed channel). Scale bar denotes 2 pA and 200 ms. (D) Ensemble average currents as determined from all sweeps recorded for all the experimental conditions. Scale bar denotes 50 fA and 400 ms. (E–G) Mean ± s.e.m. for (E) Po (%), (F) availability (i.e. likelihood that a sweep had at least one event) (%) and (G) the mean ensemble average current (fA) for each experimental condition. *p
    2019
    unknown
  6. 2019
    unknown
  7. 2019
    unknown
  8. 2019
    unknown
  9. 2019
    unknown
  10. Supplementary file 1. RNA and reduced representation bisulfite sequencing analysis. ; (A) Log2FC (lfcMLE) and adjusted p-values (padj) from DEseq2 differential expression analysis, computed by comparing female WT placentas of the forward cross (n = 8) with each of the deletion strains (deletion on Xa, n = 3–4) and female WT placentas of the reverse cross (n = 9) with each of the deletion strains (deletion on Xi, n = 3–4). (B) Log2FC (lfcMLE) and adjusted p-values (padj) from DEseq2 differential expression analysis, computed by comparing male WT placentas of the forward cross (n = 9) with each of the KO strains (n = 3). (C) Methylation levels as measured by reduced representation bisulfite sequencing (RRBS) for WT placenta and DKO deletion on Xa or Xi. (D) Imprinted ratios of X-linked placenta genes for WT and each of the deletion strains (deletions on Xa or Xi, 0.5 = 100% maternal, −0.5 = 100% paternal). The allelic ratios for each replicate per genotype was combined by using the median. (E) Imprinted ratios of X-linked visceral yolk sac genes for WT and DKO (deletions on Xa or Xi, 0.5 = 100% maternal, −0.5 = 100% paternal). The allelic ratios for each replicate per genotype was combined by using the median. (F) Differentially expressed genes (DEseq2 differential expression analysis) in all tissues (bodymap) of DKO female and liver and spleen of SKO female. (G-H) Log2FC of megadomain, superloop and Firre locus dependent gene sets in the liver and spleen. (I) Top enriched gene sets identified in the DKO and Firre SKO spleen. (J) Information of every analyzed sample in this study.
    2019
    unknown
  11. Figure 6. HCT116 cells treated with the apoptotic drug ABT-737 contain inner membrane compartments that are lacking the enclosing outer membranes. ; (A) FM of a section of resin-embedded Bax/Bak DKO HCT116 cells stably expressing GFP-Bax, treated with ABT-737 for 3 hr. GFP-Bax (green), MitoTracker Deep Red (magenta). Yellow square indicates the field of view imaged by ET, white circles indicate fluorescent signals of interest localized in electron tomograms. (B) Virtual slice through an electron tomogram acquired at area indicated by the yellow square in A. Green and magenta crosses indicate predicted position of GFP-Bax and MitoTracker Deep Red signal centroids, respectively, indicated by white circles in fluorescence micrographs. Black square indicates area magnified in C. (C) Magnified area of the virtual slice shown in B, corresponding to the black square. The image shows an accumulation of single membrane compartments near the GFP-Bax clusters. (D) 3D segmentation model of mitochondria and single-membrane compartments seen in B. Outer membranes are in dark blue, inner membranes in light blue. (E) Virtual slice through an electron cryo-tomogram of a cryo-FIB milled Bax/Bak DKO HCT116 cell stably expressing GFP-Bax treated with ABT-737 for 3 hr. Arrows indicate compartments reminiscent of mitochondrial inner membranes that appear to have no outer membrane.Arrowhead indicates an inner membrane within an intact mitochondrion. (F, G) Magnified areas of the virtual slice shown in E, corresponding to the black squares. White arrowheads indicate putative ATP synthase heads. (H) 3D segmentation model of compartments seen in E. Membranes are in light blue, putative ATP synthase heads in red. White box indicates magnified area in I. (I) Magnified area from white box in H, depicting the arrangement of putative ATP synthase heads. (J) Measured distances between head and membrane. Comparison between ATP synthases identified in mitochondria in HeLa cells, and putative ATP synthases in the compartments without outer membrane in HCT116 cells. The red lines indicate the mean and the standard deviation. For numerical data see Figure 6—source data 1. Scale bars: 500 nm (A), 100 nm (B–E, H), 20 nm (F, G, I).
    2019
    unknown
  12. Figure 2—figure supplement 2. Drug-induced GFP-Bax recruitment to mitochondria in HCT116 cells causes outer membrane ruptures and inner membrane rearrangement similar to those induced in HeLa cells upon GFP-Bax overexpression. ; Live confocal FM of Bax/Bak DKO HCT116 cells stably expressing GFP-Bax (green), treated with ABT-737 and Q-VD-OPh for 3 hr. Cells were stained with MitoTracker Deep Red (magenta) prior to treatment. Cells were imaged every 30 min for 3 hr after treatment. FM images shown are from (A) 30 min, (B) 1 hr, and (C) 2 hr 30 min following treatment. White squares indicate areas shown magnified below A-C. The three magnified images correspond to: GFP-Bax channel (left), MitoTracker Deep Red channel (middle), and merge (right). (D–F) Correlative microscopy: FM image of section of resin-embedded Bax/Bak DKO HCT116 cells stably expressing GFP-Bax (green) that were treated with ABT-737 and Q-VD-OPh for 3 hr. GFP-Bax (green), MitoTracker Deep Red (magenta). Yellow squares indicate the field of view imaged by ET. White circles indicate GFP-Bax signals localized in electron tomograms. (G–I) Virtual slices from electron tomograms acquired at areas indicated by yellow square in FM images. White arrowheads indicate ruptured membranes. Green crosses indicate predicted positions of GFP-Bax signal centroids indicated by white circles in fluorescence micrographs. (J–L) 3D segmentation model of mitochondria in G-I, respectively. Outer membranes in dark blue, inner membranes in light blue. Scale bars: 10 µm (A-C, upper panels), 2 µm (A-C, lower panels), 500 nm (D–F), 100 nm (G–L).
    2019
    unknown
  13. Figure 4. Restoring Robo1/2 exon 6b levels rescues axon guidance defects in Nova1/2 dKO embryos. ; (A) Alternative splicing of exon 6b in animals with or without the exon 6b deletion allele. Semi-quantitative RT-PCR was performed using RNA from E11.5 dorsal spinal cord. Deleting one copy of exon 6b from Robo1/2 genomic DNA in Nova1/2 dKO embryos restored e6b+ expression to a comparable level as in the WT. (B) DiI labeling of spinal cord openbooks (top panel) and anti-L1 staining of transverse spinal cord sections (bottom panel) in E12.5 animals with or without exon 6b deletion. As it is difficult to obtain a large number of compound mutants, the rostral half of the spinal cord was used for DiI labeling and the lumbar level was used for anti-L1 staining. Brackets indicate the midline. Arrows indicate the lateral funiculus (LF) and ventral funiculus (VF). Reducing Robo1(e6b+) partially rescued both midline crossing and lateral positioning defects in Nova1/2 dKO embryos, while reducing Robo2(e6b+) alone did not rescue. Reducing Robo1/2(e6b+) together further rescued both defects. Scale bars, 50 μm. (C) Quantification of axon midline crossing and lateral positioning in B. As Nova deficiency reduces the number of postcrossing axons due to fewer axons reaching the midline, we compared the ratio between the thickness of the lateral and ventral funiculi within the same section. Data are represented as the mean ± SD (one-way ANOVA and Bonferroni post test; animal numbers and p values are indicated; ns, not significant).
    2019
    unknown
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -